• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒16型L1病毒样颗粒疫苗在全血中引发广谱细胞因子反应。

HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.

作者信息

Pinto Ligia A, Castle Philip E, Roden Richard B, Harro Clayton D, Lowy Douglas R, Schiller John T, Wallace Dora, Williams Marcus, Kopp William, Frazer Ian H, Berzofsky Jay A, Hildesheim Allan

机构信息

SAIC-Frederick, Inc./NCI-Frederick, Room 120, Building 469, Frederick, MD 21702, USA.

出版信息

Vaccine. 2005 May 20;23(27):3555-64. doi: 10.1016/j.vaccine.2005.01.146.

DOI:10.1016/j.vaccine.2005.01.146
PMID:15855014
Abstract

Here, we evaluated innate and adaptive immune system cytokine responses induced by HPV-16 L1 VLP in whole blood (WB) cultures from individuals receiving the vaccine (n=20) or placebo (n=4) before and after vaccination. 11 cytokines were measured: IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IFN-gamma, TNF-alpha, and GM-CSF using multiplex bead arrays. Cytokine profiles from WB samples clearly discriminated between vaccine and placebo recipients and between pre and post-vaccination responses. Significant increases in Th1, Th2 and inflammatory cytokines were observed in WB assays following vaccination. Results from WB assays were compared against parallel PBMC-based assays in a subset of patients. Differences between whole blood assay and PBMC were observed, with the highest levels of induction found for WB for several cytokines. Our results indicate that multiplex assays for cytokine profiling in WB are an efficient tool for assessing broad spectrum, innate and adaptive immune responses to vaccines and identifying immunologic correlates of protection in efficacy studies.

摘要

在此,我们评估了在接种疫苗前和接种后,来自接种疫苗者(n = 20)或安慰剂组(n = 4)的全血(WB)培养物中,HPV - 16 L1病毒样颗粒(VLP)诱导的先天性和适应性免疫系统细胞因子反应。使用多重微珠阵列检测了11种细胞因子:IL - 1β、IL - 2、IL - 4、IL - 5、IL - 6、IL - 8、IL - 10、IL - 12、IFN - γ、TNF - α和GM - CSF。WB样本的细胞因子谱能够清晰地区分疫苗接种者和安慰剂接受者,以及接种前和接种后的反应。接种疫苗后,在WB检测中观察到Th1、Th2和炎性细胞因子显著增加。在一部分患者中,将WB检测结果与基于外周血单个核细胞(PBMC)的平行检测结果进行了比较。观察到全血检测和PBMC检测之间存在差异,几种细胞因子在WB检测中的诱导水平最高。我们的结果表明,用于WB中细胞因子谱分析的多重检测是评估对疫苗的广谱先天性和适应性免疫反应以及在疗效研究中确定保护的免疫相关因素的有效工具。

相似文献

1
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.人乳头瘤病毒16型L1病毒样颗粒疫苗在全血中引发广谱细胞因子反应。
Vaccine. 2005 May 20;23(27):3555-64. doi: 10.1016/j.vaccine.2005.01.146.
2
Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles.接种人乳头瘤病毒16型L1病毒样颗粒后的细胞因子和趋化因子谱
Clin Vaccine Immunol. 2007 Aug;14(8):984-9. doi: 10.1128/CVI.00090-07. Epub 2007 Jun 27.
3
Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Virology. 2006 Sep 30;353(2):451-62. doi: 10.1016/j.virol.2006.06.021. Epub 2006 Jul 24.
4
Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.在热敏性粘膜粘附递送系统中,用人乳头瘤病毒16型L1病毒样颗粒疫苗进行阴道内免疫后,增强的粘膜和全身免疫反应
J Med Virol. 2003 Aug;70(4):633-41. doi: 10.1002/jmv.10442.
5
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.接种重组人乳头瘤病毒16型L1病毒样颗粒的健康志愿者对人乳头瘤病毒16型(HPV-16)L1的细胞免疫反应
J Infect Dis. 2003 Jul 15;188(2):327-38. doi: 10.1086/376505. Epub 2003 Jul 9.
6
Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial.一种新型人乳头瘤病毒16型疫苗的免疫原性和反应原性:一项为期2年的随机对照临床试验
Mayo Clin Proc. 2005 May;80(5):601-10. doi: 10.4065/80.5.601.
7
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.HPV-16 L1病毒样颗粒在疫苗接种者白细胞中诱导的基因表达模式。
J Immunol. 2009 Feb 1;182(3):1706-29. doi: 10.4049/jimmunol.182.3.1706.
8
Papillomavirus-like particles for serology and vaccine development.用于血清学和疫苗开发的乳头瘤病毒样颗粒
Intervirology. 1996;39(1-2):54-61. doi: 10.1159/000150475.
9
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.用病毒样颗粒疫苗激发大学适龄女性11型人乳头瘤病毒特异性体液免疫和细胞免疫反应。
J Virol. 2002 Aug;76(15):7832-42. doi: 10.1128/jvi.76.15.7832-7842.2002.
10
Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.通过使用密码子优化的L1版本提高基于沙门氏菌的抗人乳头瘤病毒16型病毒样颗粒疫苗的效率。
J Virol. 2004 Dec;78(23):12901-9. doi: 10.1128/JVI.78.23.12901-12909.2004.

引用本文的文献

1
Immune responses to human papillomavirus infection and vaccination.对人乳头瘤病毒感染和疫苗接种的免疫反应。
Front Immunol. 2025 Jun 16;16:1591297. doi: 10.3389/fimmu.2025.1591297. eCollection 2025.
2
Association Between Vaccination for Human Papillomavirus (HPV) and Autonomic Dysfunction and Menstrual Irregularities: A Self-Controlled Case Series Analysis.人乳头瘤病毒(HPV)疫苗接种与自主神经功能障碍及月经不调之间的关联:一项自我对照病例系列分析
Drugs Real World Outcomes. 2025 Jun 16. doi: 10.1007/s40801-025-00504-y.
3
Therapeutic Role of HPV Vaccination on Benign HPV-induced Epithelial Proliferations in Immunocompetent and Immunocompromised Patients: Case Study and Review of the Literature.
HPV疫苗对免疫功能正常和免疫功能低下患者中良性HPV诱导的上皮增殖的治疗作用:病例研究及文献综述
Open Forum Infect Dis. 2024 Jul 19;11(7):ofae369. doi: 10.1093/ofid/ofae369. eCollection 2024 Jul.
4
Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review.重症肌无力是新冠疫苗的真正并发症吗?一项基于病例报告的系统评价。
Can J Infect Dis Med Microbiol. 2022 Sep 17;2022:5009450. doi: 10.1155/2022/5009450. eCollection 2022.
5
B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination.人乳头瘤病毒(HPV)感染及接种疫苗后的B细胞反应
Vaccines (Basel). 2022 May 25;10(6):837. doi: 10.3390/vaccines10060837.
6
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.黏膜疫苗的前景:关上 SARS-CoV-2 的大门。
Hum Vaccin Immunother. 2020 Dec 1;16(12):2921-2931. doi: 10.1080/21645515.2020.1805992. Epub 2020 Sep 15.
7
Myasthenia gravis following human papillomavirus vaccination: a case report.人乳头瘤病毒疫苗接种后发生的重症肌无力:一例报告
BMC Neurol. 2018 Dec 28;18(1):222. doi: 10.1186/s12883-018-1233-y.
8
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.斐济女孩接种1剂、2剂或3剂四价人乳头瘤病毒疫苗6年后的细胞免疫反应及随后接种1剂二价人乳头瘤病毒疫苗的反应
Open Forum Infect Dis. 2018 Jun 20;5(7):ofy147. doi: 10.1093/ofid/ofy147. eCollection 2018 Jul.
9
C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination.C3-Luc细胞是评估HPV16L1疫苗接种后细胞免疫的优秀模型。
PLoS One. 2016 Feb 22;11(2):e0149748. doi: 10.1371/journal.pone.0149748. eCollection 2016.
10
Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids.人乳头瘤病毒疫苗可在口腔黏膜液中诱导产生中和抗体。
Br J Cancer. 2016 Feb 16;114(4):409-16. doi: 10.1038/bjc.2015.462. Epub 2016 Feb 11.